Skip to Main Content

Paper Details

HER3 Is an Actionable Target in Advanced Prostate Cancer.
Cancer Res
28
2021
Advanced Prostate Cancer, CRPC, ERBB, ERBB receptors, HER3, HER3 protein, NRG1, PC, PDX-O, U3-1402, advanced CRPC, human, membranous, mouse, mouse PC organoids, murine, murine PC, murine bone marrow-derived macrophages, murine transgenic, myeloid-derived suppressor cells, myelomonocytic cells, patient, prostate cancer, tumor, tumor-infiltrating myelomonocytic cells
Author NameAffiliation
Susana MirandaThe Institute of Cancer Research
Adam SharpThe Institute of Cancer Research
Adam SharpThe Royal Marsden Hospital
Maryou B LambrosThe Institute of Cancer Research
Matthew ClarkeThe Institute of Cancer Research
Penny FlohrThe Institute of Cancer Research
Gunther BoysenThe Institute of Cancer Research
Nina TunariuThe Institute of Cancer Research
Nina TunariuThe Royal Marsden Hospital
Alec PaschalisThe Institute of Cancer Research
Alec PaschalisThe Royal Marsden Hospital
Suzanne CarreiraThe Institute of Cancer Research
Paul WorkmanThe Institute of Cancer Research
Andrea CalifanoColumbia University College of Physicians and Surgeons
Wei YuanThe Institute of Cancer Research
Johann S de BonoThe Institute of Cancer Research
Johann S de BonoThe Royal Marsden Hospital
  • 1 - 17

Datasets

Release 1.2